Already a member? Sign in
Oxcarbazepine is used to treat certain types of seizures in people who have epilepsy. It is an anticonvulsant. It works by decreasing abnormal excitement in the brain.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Epilepsy | 216 | 62 |
|
|
|
|
|
| Treat my mood condition(s) | 67 | 22 |
|
|
|
|
|
| Pain | 29 | 9 |
|
|
|
|
|
| Bipolar Disorder | 23 | 13 |
|
|
|
|
|
| Trigeminal neuralgia (trigeminal nerve pain) | 22 | 6 |
|
|
|||
| Other | 20 | 2 |
|
|
See all 382 patients currently taking Oxcarbazepine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Oxcarbazepine
| Excessive daytime sleepiness (somnolence) | 11 | |
|---|---|---|
| Dry mouth (xerostomia) | 10 | |
| Dizziness | 10 | |
| Weight gain | 7 | |
| Fatigue | 7 | |
| Lack of concentration | 7 | |
| See all 125 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Oxcarbazepine. See all 43 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 66 | ||
| Did not seem to work | 60 | ||
| Doctor's advice | 46 | ||
| Other | 25 | ||
| Course of treatment ended | 8 | ||
| Personal research | 6 | ||
| Change in health plan coverage | 4 | ||
| Expense | 3 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Oxcarbazepine
Always |
126 | 82% |
|
|---|---|---|---|
Usually |
19 | 12% |
|
Sometimes |
5 | 3% |
|
Never |
4 | 3% |
|
Burden
Difficulty being on treatment
Burden of Oxcarbazepine
Very |
8 | 5% |
|
|---|---|---|---|
Somewhat |
23 | 15% |
|
A little |
22 | 14% |
|
Not at all |
101 | 66% |
|
Cost
Paid out of pocket
Cost of Oxcarbazepine
$200+ |
4 | 4% |
|
|---|---|---|---|
$100-199 |
7 | 7% |
|
$50-99 |
12 | 12% |
|
$25-49 |
11 | 11% |
|
< $25 |
67 | 66% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 27, 2012.